| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Active and passive case-finding in tuberculosis-affected households in Peru: a 10-year prospective cohort study
|
Saunders, Matthew J
|
|
2019
|
19 |
5 |
p. 519-528
|
article
|
| 2 |
Advanced immunodiagnostic tests for paediatric tuberculosis
|
Villanueva, Paola
|
|
2019
|
19 |
5 |
p. 467-468
|
article
|
| 3 |
A new social sciences network for infectious threats
|
Giles-Vernick, Tamara
|
|
2019
|
19 |
5 |
p. 461-463
|
article
|
| 4 |
A solution to the problem of antibiotic induced collateral damage to the gut microbiome
|
Goldenberg, Simon D
|
|
2019
|
19 |
5 |
p. 451-452
|
article
|
| 5 |
Bedaquiline and delamanid in combination for treatment of drug-resistant tuberculosis
|
Mohr, Erika
|
|
2019
|
19 |
5 |
p. 470
|
article
|
| 6 |
C difficile—a rose by any other name…
|
The Lancet Infectious Diseases,
|
|
2019
|
19 |
5 |
p. 449
|
article
|
| 7 |
Ceftriaxone-resistant Salmonella Typhi in a traveller returning from a mass gathering in Iraq
|
Godbole, Gauri
|
|
2019
|
19 |
5 |
p. 467
|
article
|
| 8 |
Control of scabies and secondary impetigo: optimising treatment effectiveness in endemic settings
|
Chosidow, Olivier
|
|
2019
|
19 |
5 |
p. 454-456
|
article
|
| 9 |
Correction to Lancet Infect Dis 2019; 19: 348–49
|
|
|
2019
|
19 |
5 |
p. e148
|
article
|
| 10 |
Correction to Lancet Infect Dis 2019; 19: e77–88
|
|
|
2019
|
19 |
5 |
p. e148
|
article
|
| 11 |
Corruption is an “ignored pandemic”
|
Burki, Talha
|
|
2019
|
19 |
5 |
p. 471
|
article
|
| 12 |
Diagnosis and treatment of human sparganosis
|
Galán-Puchades, M Teresa
|
|
2019
|
19 |
5 |
p. 465
|
article
|
| 13 |
Ebola: public trust, intermediaries, and rumour in the DR Congo
|
Trapido, Joe
|
|
2019
|
19 |
5 |
p. 457-458
|
article
|
| 14 |
Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis
|
van Eijk, Anna Maria
|
|
2019
|
19 |
5 |
p. 546-556
|
article
|
| 15 |
Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, non-inferiority trial
|
Ibrahim, Laila F
|
|
2019
|
19 |
5 |
p. 477-486
|
article
|
| 16 |
Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial
|
Romani, Lucia
|
|
2019
|
19 |
5 |
p. 510-518
|
article
|
| 17 |
Epidemic preparedness: why is there a need to accelerate the development of diagnostics?
|
Peeling, Rosanna W
|
|
2019
|
19 |
5 |
p. e172-e178
|
article
|
| 18 |
Epidemics of plague past, present, and future
|
Mead, Paul
|
|
2019
|
19 |
5 |
p. 459-460
|
article
|
| 19 |
Epidemiological characteristics of an urban plague epidemic in Madagascar, August–November, 2017: an outbreak report
|
Randremanana, Rindra
|
|
2019
|
19 |
5 |
p. 537-545
|
article
|
| 20 |
Immunogenicity and reactogenicity of ten-valent versus 13-valent pneumococcal conjugate vaccines among infants in Ho Chi Minh City, Vietnam: a randomised controlled trial
|
Temple, Beth
|
|
2019
|
19 |
5 |
p. 497-509
|
article
|
| 21 |
Infection in the immunocompromised host
|
Thomas, Mark
|
|
2019
|
19 |
5 |
p. 476
|
article
|
| 22 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
2019
|
19 |
5 |
p. 474
|
article
|
| 23 |
Institutional trust and misinformation in the response to the 2018–19 Ebola outbreak in North Kivu, DR Congo: a population-based survey
|
Vinck, Patrick
|
|
2019
|
19 |
5 |
p. 529-536
|
article
|
| 24 |
Linezolid for drug-susceptible tuberculosis
|
Han, Jiyeon
|
|
2019
|
19 |
5 |
p. 468-469
|
article
|
| 25 |
Mimicking oesophageal cancer: oesophageal actinomycosis
|
Deswysen, Yannick
|
|
2019
|
19 |
5 |
p. 558
|
article
|
| 26 |
OPAT for avoidance of hospitalisation in children
|
Krah, Nathan M
|
|
2019
|
19 |
5 |
p. 450-451
|
article
|
| 27 |
PERISCOPE: road towards effective control of pertussis
|
|
|
2019
|
19 |
5 |
p. e179-e186
|
article
|
| 28 |
Research brief
|
Mohammadi, Dara
|
|
2019
|
19 |
5 |
p. 475
|
article
|
| 29 |
Residual cavity hydrops initially misdiagnosed as recurrent hepatic echinococcosis
|
Wu, Kan
|
|
2019
|
19 |
5 |
p. 557
|
article
|
| 30 |
Sensitivity and negative predictive value for a rapid dengue test
|
Flasche, Stefan
|
|
2019
|
19 |
5 |
p. 465-466
|
article
|
| 31 |
Serocorrelates of protection against infant group B streptococcus disease
|
Le Doare, Kirsty
|
|
2019
|
19 |
5 |
p. e162-e171
|
article
|
| 32 |
Taiwan commits to eliminating hepatitis C in 2025
|
Chen, Ding-Shinn
|
|
2019
|
19 |
5 |
p. 466-467
|
article
|
| 33 |
The duopoly of ten-valent and 13-valent pneumococcal conjugate vaccines: do they differ?
|
Madhi, Shabir A
|
|
2019
|
19 |
5 |
p. 453-454
|
article
|
| 34 |
The remarkable tenacity of sulfadoxine-pyrimethamine
|
Divala, Titus H
|
|
2019
|
19 |
5 |
p. 460-461
|
article
|
| 35 |
Tuberculosis active case-finding: more than just finding cases
|
Mitnick, Carole D
|
|
2019
|
19 |
5 |
p. 456-457
|
article
|
| 36 |
Tuberculosis mortality targets off-track
|
Burki, Talha
|
|
2019
|
19 |
5 |
p. 472
|
article
|
| 37 |
Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial
|
Kokai-Kun, John F
|
|
2019
|
19 |
5 |
p. 487-496
|
article
|
| 38 |
Venezuela's humanitarian crisis, resurgence of vector-borne diseases, and implications for spillover in the region
|
Grillet, Maria E
|
|
2019
|
19 |
5 |
p. e149-e161
|
article
|
| 39 |
2019 WHO hand hygiene campaign and global survey: clean care for all—it's in your hands
|
Peters, Alexandra
|
|
2019
|
19 |
5 |
p. 463-464
|
article
|
| 40 |
WHO takes a new approach to Buruli ulcer
|
Barksby, Rebecca
|
|
2019
|
19 |
5 |
p. 473-474
|
article
|
| 41 |
Zika's passage to India
|
Rolph, Michael S
|
|
2019
|
19 |
5 |
p. 469-470
|
article
|
Journal description